Literature DB >> 15907287

Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene.

Olimpia Musumeci1, Carmelo Rodolico, Ichizo Nishino, Giuseppe Di Guardo, Alba Migliorato, Mohammed Aguennouz, Anna Mazzeo, Corrado Messina, Giuseppe Vita, Antonio Toscano.   

Abstract

Primary lysosome-associated membrane protein-2 (LAMP-2) deficiency is an X-linked disease, characterized by the clinical triad of cardiomyopathy, vacuolar myopathy and mental retardation, previously known as Danon disease. Mutations of lamp-2 gene have been reported so far in about 20 patients, one of whom was Italian. We describe a new Italian case with persistent hyperCKemia, exercise intolerance and hypertrophic cardiomyopathy but with no muscle weakness or mental impairment. Muscle biopsy revealed a vacuolar myopathy with mild glycogen storage, and immunohistochemical studies detected LAMP-2 deficiency. A new nucleotide substitution (T961C) on exon 8 of lamp-2 gene was identified as responsible for the protein deficiency. This is the first missense mutation so far described. LAMP-2 deficiency should be considered as a cause of recurrent hyperCKemia and hypertrophic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907287     DOI: 10.1016/j.nmd.2005.02.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

1.  LAMP2 microdeletions in patients with Danon disease.

Authors:  Zhao Yang; Birgit H Funke; Linda H Cripe; G Wesley Vick; Debora Mancini-Dinardo; Liana S Peña; Ronald J Kanter; Brenda Wong; Brandy H Westerfield; Jaquelin J Varela; Yuxin Fan; Jeffrey A Towbin; Matteo Vatta
Journal:  Circ Cardiovasc Genet       Date:  2010-02-20

2.  LAMP-2 deficiency (Danon disease).

Authors:  S Di Mauro; K Tanji; M Hirano
Journal:  Acta Myol       Date:  2007-07

Review 3.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

4.  Danon disease: intrafamilial phenotypic variability related to a novel LAMP-2 mutation.

Authors:  Sarah-Louise Cottinet; Anne-Marie Bergemer-Fouquet; Annick Toutain; Frédérique Sabourdy; Zoha Maakaroun-Vermesse; Thierry Levade; Alain Chantepie; François Labarthe
Journal:  J Inherit Metab Dis       Date:  2010-12-16       Impact factor: 4.982

5.  LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart.

Authors:  Ronny Alcalai; Michael Arad; Hiroko Wakimoto; Dor Yadin; Joshua Gorham; Libin Wang; Elia Burns; Barry J Maron; William C Roberts; Tetsuo Konno; David A Conner; Antonio R Perez-Atayde; Jon G Seidman; Christine E Seidman
Journal:  J Am Heart Assoc       Date:  2021-08-28       Impact factor: 6.106

Review 6.  Danon disease: clinical features, evaluation, and management.

Authors:  Ryan S D'souza; Cecilia Levandowski; Dobromir Slavov; Sharon L Graw; Larry A Allen; Eric Adler; Luisa Mestroni; Matthew R G Taylor
Journal:  Circ Heart Fail       Date:  2014-09       Impact factor: 8.790

7.  Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease.

Authors:  Marina Fanin; Anna C Nascimbeni; Luigi Fulizio; Marco Spinazzi; Paola Melacini; Corrado Angelini
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

8.  A novel LAMP2 p.G93R mutation associated with mild Danon disease presenting with familial hypertrophic cardiomyopathy.

Authors:  Jing Xu; Lu Wang; Xiangdong Liu; Qiming Dai
Journal:  Mol Genet Genomic Med       Date:  2019-08-28       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.